Clinically reviewed by Dr. Sarah Boss, MD
Slow or difficult breathing, collapse or inability to wake someone requires emergency help and available naloxone according to its instructions. Suspected overdose of a paracetamol-containing combination needs immediate advice even without symptoms. Do not crush prolonged-release tablets or abruptly stop established treatment yourself.
Dihydrocodeine is an opioid painkiller used for moderate to severe pain in appropriate circumstances. It can also appear in combination products, which creates important differences in safety and instructions. A familiar medicine name does not make prolonged use risk-free. Reviewing dihydrocodeine means considering pain relief, everyday functioning, emotional well-being, dependence and the other medicines taken alongside it.
What dihydrocodeine is used for
Dihydrocodeine changes the way the nervous system responds to pain. It is available in immediate-release and prolonged-release preparations, with brands such as DF118 Forte and DHC Continus in some markets. The exact product, strength and purpose should be confirmed from the dispensing label. A slow-release prescription is not automatically interchangeable with tablets intended to release the medicine more quickly. [1]
Ask what problem the prescription is intended to solve and how success will be reviewed. Pain intensity is only one part of the picture; walking, sleep, personal care or comfortable participation in daily life may matter as much. New pain or a changing pattern deserves assessment rather than an automatic increase in the opioid.
Combination products require an extra check
Co-dydramol contains dihydrocodeine and paracetamol. Some other products, including Paramol, also contain both ingredients but have their own strengths and instructions. Taking extra paracetamol or a cold remedy can duplicate the non-opioid ingredient. Suspected excess paracetamol requires immediate medical advice even if no symptoms are present, because liver injury may not be obvious at first. [2] [3]
Do not compare combination products only by the number of tablets. Ask a pharmacist to review the actual packages, including medicines bought without a prescription. The fact that a small pack is available from a pharmacy does not mean it is suitable for long-term use or for someone taking another sedative. Follow the product’s duration limits and seek advice when pain continues.
Taking the actual prescribed formulation
Slow-release tablets should be swallowed as directed and not crushed or chewed. Damaging the release mechanism can deliver too much opioid at once. A liquid, where prescribed, needs the correct concentration and an appropriate measuring device. If a dose is missed or vomiting occurs, consult the product instructions or pharmacist rather than doubling the next dose. [4]
When a prescription changes, establish whether the earlier medicine is being replaced or retained for a specific purpose. Keep one current list of what you actually take. Bringing the packaging to a review is often more useful than describing tablets by their color, especially when different manufacturers or countries use different presentations.
Common side effects
Constipation, nausea, vomiting, drowsiness and dizziness can occur. Speak to the clinician or pharmacist when these persist or interfere with daily life. A bowel-management plan may be needed, but severe abdominal swelling, repeated vomiting or inability to pass stool or gas requires assessment rather than simply taking more laxatives. Do not drive, cycle or use machinery while impaired. [5]
Describe the effect concretely: difficulty staying awake at work, a fall when getting out of bed or nausea that prevents meals. Record whether it started after a change in dihydrocodeine, another medicine or an illness. This helps distinguish a manageable adverse effect from a situation that needs a different treatment approach.
Breathing problems and urgent symptoms
Opioids can suppress breathing. Slow or difficult breathing, collapse or inability to wake someone needs emergency help. Call local emergency services, use available naloxone according to its instructions and follow the dispatcher’s advice. Do not leave the person alone or assume that an improvement after a reversal medicine removes the need for assessment. [2]
Serious allergy, a seizure or severe confusion also needs urgent care. If a combination product was taken, tell the team all its ingredients and the amount that may have been used. An opioid reversal medicine does not treat paracetamol poisoning. Keep the packaging available for clinicians, but do not delay calling for help while searching for it.
Interactions with alcohol and psychiatric medicines
Alcohol, benzodiazepines, sleeping medicines and other opioids can increase sedation and breathing risk. Antidepressants, antipsychotics and medicines used for nerve pain or seizures may also require review. A pharmacist needs to know about non-prescription antihistamines, herbal products and occasional medicines, not just the regular prescriptions. [6]
Do not skip psychiatric treatment in order to take extra pain medicine or drink alcohol. A general interaction warning is a reason to coordinate the plan, not to make an abrupt independent change. When several services prescribe, ask who will reconcile the list and communicate the final instructions. This is particularly important at admission, discharge or a change of pharmacy.
Mental health applications and concerns
Dihydrocodeine is not an established treatment for depression, anxiety, trauma symptoms or insomnia. Pain relief can improve comfort, but an opioid should not become an unreviewed way to numb emotional distress. Tell the clinician when the reason for taking a dose has shifted from pain to sleep, worry or avoiding unpleasant feelings. That conversation can identify care that is missing.
Persistent pain and mental health problems should be assessed together without assuming that either is the sole cause. Describe mood, concentration, sleep and functioning separately from pain scores. A coordinated plan may include psychological treatment and non-opioid pain strategies while still recognizing the person’s physical symptoms and preferences.
Tolerance, physical dependence and addiction
Repeated opioid use can lead to tolerance and physical dependence. Tolerance means the response changes; dependence means withdrawal can occur after stopping or a substantial reduction. Neither concept alone establishes opioid use disorder. That diagnosis requires assessment of a wider pattern of control, harm and use, rather than a conclusion based only on a missed-dose reaction. [2]
Raise concerns about craving, escalating use, repeated early depletion or difficulty following the agreement. Explain poor pain control and prescription-access problems too. The aim is to make the situation understandable, not to present a perfect medication history. A factual record allows the clinician to consider pain care, withdrawal support and addiction treatment where each is relevant.
Withdrawal and detox questions
After regular use, abrupt stopping may cause sweating, restlessness, aches, stomach upset, poor sleep and anxiety. The timing and severity vary with the formulation, duration and actual exposure. A reduction plan should account for the painful condition and the person’s mental health, not only the tablet count. Do not copy a taper from another person or use alcohol or borrowed sedatives to manage symptoms. [4]
If opioid use disorder is diagnosed, a painkiller prescription or a brief detox is not a complete ongoing treatment plan. Buprenorphine, methadone or naltrexone may be considered in an appropriate clinical pathway, with different starting requirements. Continuing care and overdose prevention remain important after withdrawal, especially because returning to a previously tolerated amount can be dangerous after tolerance falls. [7]
What a useful medication review includes
Bring the medicine packages, a list of other substances and a short account of benefits and unwanted effects. Include how often you actually take the medicine, whether the effect lasts as expected and what happens when a dose is missed. Agree who will review any change, how pain will be managed and what symptoms should prompt contact before the next appointment.
The medication-review checklist can help organize those questions. The opioid withdrawal guide explains why withdrawal support and longer-term treatment should not be confused. Neither resource substitutes for the product-specific instructions or a clinician’s assessment of your circumstances.
Pregnancy, breastfeeding and medical conditions
Pregnancy, breastfeeding, breathing disorders, kidney or liver problems and older age can change prescribing decisions. The team should know about these factors before a new prescription and whenever health changes. Regular opioid exposure during pregnancy may affect the newborn, while combination products introduce additional considerations. Obtain individualized advice rather than stopping established treatment suddenly because of a general warning. [2]
Secure storage matters in every household, including when children visit. Do not share medicine or keep loose tablets in an unmarked container. Ask the pharmacist how to dispose of unwanted supplies. Planning safe access and storage is a practical part of treatment, not a judgment about the person taking it.
Frequently asked questions
Is dihydrocodeine the same as codeine?
No. They are different medicines. Similar names and related uses do not make equal tablet numbers or doses interchangeable. The prescriber or pharmacist should explain any intended change.
Can a pharmacy combination cause dependence?
Yes, a product containing dihydrocodeine still contains an opioid. Follow the package’s instructions and duration limit, and seek advice if you feel unable to stop or need it repeatedly.
What should I do when pain treatment feels difficult to control?
Arrange an assessment and describe the actual pattern of use, pain and distress. Help can address more than one problem at once. Do not attempt a rapid home detox or conceal other medicines that may change the safety of the plan.
Questions about repeated short courses
Repeated short courses deserve review as well as a single long prescription. Bring the dates and reasons for each course, including products bought from a pharmacy. A clinician can then consider whether the original problem has resolved, whether a new diagnosis needs investigation and whether the medicine has become part of a recurring pattern of coping with pain or distress.
Describe any difference between the intended instructions and actual use. For example, needing the medicine at night even when daytime pain has improved may raise questions about sleep, withdrawal or another problem. This observation does not establish the answer, but it helps the team ask the right questions. Do not test the explanation by suddenly stopping, adding sedatives or changing the formulation yourself.
Agree a concrete next step: a review of the painful condition, a pharmacy check of combination ingredients, a supported treatment change or a more detailed assessment of dependence. Write down who will follow it up and when. A clear plan is more useful than leaving with an unchanged repeat prescription and unresolved concerns about what the medicine is now doing for you.
